GALMED PHARMACEUTICALS LTD. Available-for-sale Equity Securities, Gross Unrealized Loss
GALMED PHARMACEUTICALS LTD. (GLMD) reported Available-for-sale Equity Securities, Gross Unrealized Loss of $67.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedLoss · last filed 2019-03-13
| Period end | Available-for-sale Equity Securities, Gross Unrealized Loss 12 month | Available-for-sale Equity Securities, Gross Unrealized Loss 12 month as first filed |
|---|---|---|
| 2018-12-31 | $67.00K 20-F · filed 2019-03-13 | |
| 2017-12-31 | $14.00K 20-F · filed 2019-03-13 | |
| 2016-12-31 | $96.00K 20-F · filed 2018-03-13 | |
| 2015-12-31 | $217.00K 20-F · filed 2017-03-23 | $214.00K 20-F · filed 2016-03-22 |
| 2014-12-31 | $3.00K 20-F · filed 2016-03-22 | |
| 2013-12-31 | $0.00 20-F · filed 2015-03-31 |